Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

SSII Wins Outstanding Company at 2026 Surgical Robotics Awards

SS Innovations said on June 30 that it won the “outstanding company” category at the 2026 Surgical Robotics Industry Awards, beating nine other finalists.

The company also reported that, as of June 22, 2026, cumulative procedures performed with its SSI Mantra surgical robotic system reached 11,719. That total included 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries.

Training on the system has reached about 2,100 physicians, and the platform has been used for more than 170 different types of procedures.

SS Innovations said the SSI Mantra has now received regulatory approval in 14 countries: Colombia, Ecuador, Guatemala, Guyana, India, Indonesia, Iraq, Kenya, Nepal, Oman, the Philippines, Sri Lanka, Ukraine and the United Arab Emirates. Today the company's shares have moved 6.26% to a price of $3.751. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS